Tamsi, Aurea D.
HRN: 24-78-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/14/2024
04/21/2024
IV
600mg
Q8h
Femoral Neck Fracture Sec To Fall
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes